Skip to main content
. 2018 Sep 10;2018(9):CD012453. doi: 10.1002/14651858.CD012453.pub2

Frigas 2007.

Methods Prospective, double‐blind, placebo‐controlled trial
Participants 8 patients with chronic rhinosinusitis and mild asthma
Interventions Group 1: 200 mg of itraconazole, twice daily for 4 weeks; Group 2: placebo tablets, twice daily for 4 weeks
Outcomes Chronic rhinosinusitis symptoms, sinus CT scan
Notes Abstract only. Contacted authors for more information but no response was received. Abstract published in 2007; it is unlikely that this study will be published in full.